Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Amerikaanse aandelen« Terug naar discussie overzicht

Cannabis aandelen

8.267 Posts
Pagina: «« 1 ... 99 100 101 102 103 ... 414 »» | Laatste | Omlaag ↓
  1. Empros 28 februari 2018 01:29
    Cronos Has Been Approved To Trade On The Nasdaq And One Of These 5 Companies Could Be Next

    technical420.com/cannabis-article/cro...

    "We are bullish on this development and some of the companies we expect to commence trading on the Nasdaq in 2018 include: Canopy Growth Corp (WEED.TO) (TWMJF), Aurora Cannabis (ACB.TO) (ACBFF), MedReleaf (LEAF.TO) (MEDFF), The Green Organic Dutchman (private) and Aphria (APH.TO) (APHQF) after the company divests its United States cannabis assets."

    Nasdaq = catalyst !
  2. Empros 28 februari 2018 10:27
    quote:

    Empros schreef op 28 februari 2018 00:44:

    Nu dat J.Powell zijn zegje heeft gehad en de onzekerheid mbt verdere renteverhogingen zekerheid is geworden zal er mijns inziens de rust terug keren op de markten.
    Vanaf morgen terug het eerste groen!
    Vandaag Emblem bijgekocht.
    Ik ben iets te optimistisch vrees ik wat het kleurtje betreft! ...

    beter nieuws voor de medicinale cannabis in zicht mbt J;Sessions strijd tegen de opioids...

    Justice Department to target opioid manufacturers and distributors in a new push to curb deadly epidemic

    www.latimes.com/politics/la-na-pol-op...
  3. Empros 28 februari 2018 10:41
    quote:

    Empros schreef op 28 februari 2018 10:27:

    [...]

    Ik ben iets te optimistisch vrees ik wat het kleurtje betreft! ...

    beter nieuws voor de medicinale cannabis in zicht mbt J;Sessions strijd tegen de opioids...

    Justice Department to target opioid manufacturers and distributors in a new push to curb deadly epidemic

    www.latimes.com/politics/la-na-pol-op...

    Inmiddels blijft het algemeen rood.......
    Saying economy is strengthening, Fed’s Powell suggests faster pace of interest rate hikes

    www.latimes.com/business/la-fi-powell...

    "His comments about 40 minutes into the hearing caused the yield on 10-year Treasury bonds to jump and major stock indexes to begin dropping as investors anticipated a fourth rate hike this year, which would be designed to slow growth to keep the economy from overheating."
  4. [verwijderd] 28 februari 2018 13:22
    Nieuws uit Canada

    Budget eases taxes on THC-based drugs; lays foundation for pharmacare in 2019

    OTTAWA -- The federal Liberals will appoint a group of advisers to explore options for a national program to cover the costs of prescription drugs -- and are already making it easier to cover the cost of cannabis-based pharmaceuticals.

    The next year will see former Ontario health minister Eric Hoskins head up an advisory council to come up with options on how to create a national pharmacare program -- a program that the parliamentary budget watchdog has warned could cost $19 billion a year.

    The council gives the government a year to study the idea, which has been a key talking point for NDP Leader Jagmeet Singh -- fuelling speculation that the Liberals plan to make pharmacare a centrepiece of its 2019 election campaign.

    In the meantime, the Liberals say they won't apply new sales taxes to cannabis-based pharmaceutical products that can be obtained with a prescription.

    Nor will taxes be applied to oils that contain low amounts of THC, the primary psychoactive element in marijuana, that are used by children with certain medical conditions.

    As well, the government says it plans to look at creating a rebate program to retroactively reimburse patients an unspecified amount for taxes already paid on cannabis-based pharmaceuticals.

    De laatste alinea's moeten toch voor een mooie up zorgen vandaag want we kunnen wel weer eens een paar dagen groen gebruiken.
  5. Rider 28 februari 2018 14:10
    quote:

    eri09 schreef op 28 februari 2018 13:22:

    Nieuws uit Canada

    Budget eases taxes on THC-based drugs; lays foundation for pharmacare in 2019

    OTTAWA -- The federal Liberals will appoint a group of advisers to explore options for a national program to cover the costs of prescription drugs -- and are already making it easier to cover the cost of cannabis-based pharmaceuticals.

    The next year will see former Ontario health minister Eric Hoskins head up an advisory council to come up with options on how to create a national pharmacare program -- a program that the parliamentary budget watchdog has warned could cost $19 billion a year.

    The council gives the government a year to study the idea, which has been a key talking point for NDP Leader Jagmeet Singh -- fuelling speculation that the Liberals plan to make pharmacare a centrepiece of its 2019 election campaign.

    In the meantime, the Liberals say they won't apply new sales taxes to cannabis-based pharmaceutical products that can be obtained with a prescription.

    Nor will taxes be applied to oils that contain low amounts of THC, the primary psychoactive element in marijuana, that are used by children with certain medical conditions.

    As well, the government says it plans to look at creating a rebate program to retroactively reimburse patients an unspecified amount for taxes already paid on cannabis-based pharmaceuticals.

    De laatste alinea's moeten toch voor een mooie up zorgen vandaag want we kunnen wel weer eens een paar dagen groen gebruiken.
    Bedankt om te delen. Koers zit idd wat vast de laatste weken. Tegen eind dit jaar legalisering in Canada dan zullen de koersen enorm stijgen
  6. Empros 28 februari 2018 15:36
    quote:

    eri09 schreef op 28 februari 2018 13:22:

    Nieuws uit Canada

    Budget eases taxes on THC-based drugs; lays foundation for pharmacare in 2019

    OTTAWA -- The federal Liberals will appoint a group of advisers to explore options for a national program to cover the costs of prescription drugs -- and are already making it easier to cover the cost of cannabis-based pharmaceuticals.

    The next year will see former Ontario health minister Eric Hoskins head up an advisory council to come up with options on how to create a national pharmacare program -- a program that the parliamentary budget watchdog has warned could cost $19 billion a year.

    The council gives the government a year to study the idea, which has been a key talking point for NDP Leader Jagmeet Singh -- fuelling speculation that the Liberals plan to make pharmacare a centrepiece of its 2019 election campaign.

    In the meantime, the Liberals say they won't apply new sales taxes to cannabis-based pharmaceutical products that can be obtained with a prescription.

    Nor will taxes be applied to oils that contain low amounts of THC, the primary psychoactive element in marijuana, that are used by children with certain medical conditions.

    As well, the government says it plans to look at creating a rebate program to retroactively reimburse patients an unspecified amount for taxes already paid on cannabis-based pharmaceuticals.

    De laatste alinea's moeten toch voor een mooie up zorgen vandaag want we kunnen wel weer eens een paar dagen groen gebruiken.
    AB & Inderdaad gaat dit extra wind in de zeilen geven voor de medicinale cannabis!.

  7. [verwijderd] 28 februari 2018 18:05
    quote:

    Empros schreef op 28 februari 2018 16:48:

    AURORA CANNABIS ANNOUNCES FINAL REGULATORY APPROVAL FOR CANNIMED THERAPEUTICS ACQUISITION

    www.stockwatch.com/News/Item.aspx?bid...
    had ik ook gezien nu maar gewoon een +10% en morgen weer verder up up up en nu moeten ze in de US weer niet gek gaan doen net als gisteravond.
  8. Empros 1 maart 2018 00:47
    Record Canadian Cannabis IPO in 21 Days / TGOD - The Green Organic Dutchman / Toronto 19/03

    Cannabis Stocktrades
    February 28, 2018 - Issue Date
    Michael Vodicka, Editor

    On March 19, the Toronto Stock Exchange is expected to break its record for the largest cannabis IPO ever.

    This up and coming Canadian cannabis company:
    Secured coveted licenses from Canadian regulators to grow and sell cannabis.
    Raised $160 million in private capital.
    Is building cannabis greenhouses that could total 1 million square feet.
    Is positioned and branded as an organic, low-cost provider.
    The Green Organic Dutchman (TSX: TGOD) is looking to make a big splash in Canada's recreational cannabis market.
    Shares of TGOD are scheduled to begin trading on the Toronto Stock Exchange on March 19.
    Just like Medreleaf last summer, this is expected to be the largest Canadian cannabis IPO ever with a projected market value of potentially more than $1 billion.
    Its size alone makes this a cannabis IPO we want to follow.
    However, TGOD also looks well positioned to cash in on Canada's high-growth recreational market.
    TGOD Has Secured Permits from Canadian Regulators to Grow and Sell Cannabis
    Getting a permit to grow or sell cannabis in Canada is not easy. It can take years and cost tens of millions of dollars. At this point, around 50 permits have been issued while thousands remain backlogged or rejected.
    TGOD has already cleared this regulatory hurdle.
    In August 2016, TGOD received a license to cultivate cannabis.
    And one year later in August of 2017, TGOD received a license to sell cannabis.
    TGOD isn't exactly a first mover in Canada's cannabis industry. But these permits alone place TGOD ahead of hundreds of other competitors still struggling to their hands on a permit that could be months or even years away.
    TGOD Raised $160 Million in Private Capital in the Last 12 Months
    TGOD looks well funded. The company has already raised $160 million in private funding.

    $55 million of that funding came from Aurora Cannabis (ACBFF), one of the largest cannabis companies in Canada and an early industry leader.

    The IPO will give TGOD even more cash to invest in growth.

    TGOD is in the Early Stages of Building a 1 Million Square Foot Cannabis Greenhouse
    TGOD is using its cash to build two state of the art cannabis greenhouses that could total more than 1 million square feet.

    On September 27, TGOD announced it had purchased a 75-acre property located in Salaberry-de-Valleyfield, Quebec (the "Quebec Property").

    TGOD has big plans for its Quebec property - with the potential to house 820,000 square feet of production.

    The facility is being developed in phases. Phase one started last fall.
    TGOD is also expanding an Ontario facility, which could eventually reach 150,000 square feet of production capacity.
    With these two facilities coming online, and growing production capacity sharply in the next 12 months, TGOD looks well positioned to cash in Canada's high-growth recreational market.

    Positioned as Organic, Low-Cost Producer
    TGOD is creating a unique selling proposition in the Canadian cannabis sector as an organic producer. This kind of market niche and consumer branding can go a long way for sales growth and brand loyalty, and I think its a smart angle.

    www.newswire.ca/news-releases/aurora-...

8.267 Posts
Pagina: «« 1 ... 99 100 101 102 103 ... 414 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.